Press "Enter" to skip to content

Indian pharma majors deny allegations of price fixing in US

The company said its US subsidiary is specifically named as a defendant with respect to five generic drugs (Ciprofloxacin HCL tablets, Glimepiride tablets, Oxaprozin tablets, Paricalcitol and Tizanidine), for an alleged "overarching conspiracy".

Original source: https://health.economictimes.indiatimes.com/news/pharma/indian-pharma-majors-deny-allegations-of-price-fixing-in-us/69334548?utm_source=RSS&utm_medium=ETRSS

Also Read:   Delay in notification of e-pharmacy draft rules causing concern in the sector: Ficci